Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20647 | 450 | 27.0 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
3041 | 2 | PSK//OK 432//IMEXON | 2463 |
20647 | 1 | OK 432//AEGINETIA INDICA L//PROD LIFECYCLE MED INFORMAT | 450 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | OK 432 | authKW | 2872874 | 25% | 38% | 111 |
2 | AEGINETIA INDICA L | authKW | 339277 | 1% | 100% | 5 |
3 | PROD LIFECYCLE MED INFORMAT | address | 271422 | 1% | 100% | 4 |
4 | PROD S | address | 255756 | 2% | 54% | 7 |
5 | OK 432 PICIBANIL | authKW | 180945 | 1% | 67% | 4 |
6 | AEGINETIA INDICA ROXBERT | authKW | 135711 | 0% | 100% | 2 |
7 | DEMETHYLPODOPHYLLOTOXIN | authKW | 135711 | 0% | 100% | 2 |
8 | TH1 TYPE CYTOKINES | authKW | 108564 | 1% | 40% | 4 |
9 | SAPYLIN | authKW | 90473 | 0% | 67% | 2 |
10 | 13 CIS RETINOIC ACID 13 CRA | authKW | 67855 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 3050 | 43% | 0% | 193 |
2 | Immunology | 2503 | 36% | 0% | 163 |
3 | Medicine, Research & Experimental | 428 | 12% | 0% | 56 |
4 | Pharmacology & Pharmacy | 212 | 15% | 0% | 67 |
5 | Gastroenterology & Hepatology | 58 | 4% | 0% | 19 |
6 | Surgery | 52 | 8% | 0% | 36 |
7 | Medical Laboratory Technology | 19 | 1% | 0% | 6 |
8 | Otorhinolaryngology | 19 | 2% | 0% | 8 |
9 | Microbiology | 16 | 4% | 0% | 18 |
10 | Cell Biology | 15 | 5% | 0% | 23 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROD LIFECYCLE MED INFORMAT | 271422 | 1% | 100% | 4 |
2 | PROD S | 255756 | 2% | 54% | 7 |
3 | AFFLICTED HOSP | 67855 | 0% | 100% | 1 |
4 | HIGASHI KU ABORAT | 67855 | 0% | 100% | 1 |
5 | INTERNAL MEDBRAIN KOREA 21 PROJECT MED | 67855 | 0% | 100% | 1 |
6 | LIAOCHENG HOSP | 67855 | 0% | 100% | 1 |
7 | POST MARKETING CLIN TRIAL | 67855 | 0% | 100% | 1 |
8 | RADIAT BIOL MARINE | 67855 | 0% | 100% | 1 |
9 | SHINJUKU KU ADV MED | 67855 | 0% | 100% | 1 |
10 | STUDY GRP GASTR CANC | 67855 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOTHERAPY | 33212 | 3% | 4% | 12 |
2 | JAPANESE JOURNAL OF EXPERIMENTAL MEDICINE | 28760 | 3% | 3% | 14 |
3 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 21385 | 8% | 1% | 37 |
4 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 16191 | 5% | 1% | 22 |
5 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 6814 | 2% | 1% | 7 |
6 | ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION C-IMMUNOLOGY | 5649 | 1% | 3% | 3 |
7 | IMMUNOPHARMACOLOGY | 4121 | 2% | 1% | 9 |
8 | NATURAL IMMUNITY AND CELL GROWTH REGULATION | 3909 | 1% | 2% | 3 |
9 | GANN | 3263 | 1% | 1% | 6 |
10 | JOURNAL OF IMMUNOTHERAPY | 3254 | 2% | 1% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OK 432 | 2872874 | 25% | 38% | 111 | Search OK+432 | Search OK+432 |
2 | AEGINETIA INDICA L | 339277 | 1% | 100% | 5 | Search AEGINETIA+INDICA+L | Search AEGINETIA+INDICA+L |
3 | OK 432 PICIBANIL | 180945 | 1% | 67% | 4 | Search OK+432+PICIBANIL | Search OK+432+PICIBANIL |
4 | AEGINETIA INDICA ROXBERT | 135711 | 0% | 100% | 2 | Search AEGINETIA+INDICA+ROXBERT | Search AEGINETIA+INDICA+ROXBERT |
5 | DEMETHYLPODOPHYLLOTOXIN | 135711 | 0% | 100% | 2 | Search DEMETHYLPODOPHYLLOTOXIN | Search DEMETHYLPODOPHYLLOTOXIN |
6 | TH1 TYPE CYTOKINES | 108564 | 1% | 40% | 4 | Search TH1+TYPE+CYTOKINES | Search TH1+TYPE+CYTOKINES |
7 | SAPYLIN | 90473 | 0% | 67% | 2 | Search SAPYLIN | Search SAPYLIN |
8 | 13 CIS RETINOIC ACID 13 CRA | 67855 | 0% | 100% | 1 | Search 13+CIS+RETINOIC+ACID+13+CRA | Search 13+CIS+RETINOIC+ACID+13+CRA |
9 | 70 PERCENT HEPATECTOMY | 67855 | 0% | 100% | 1 | Search 70+PERCENT+HEPATECTOMY | Search 70+PERCENT+HEPATECTOMY |
10 | ADRENOCHROME MONOAMINOGUANIDINE METHANESULFONATE | 67855 | 0% | 100% | 1 | Search ADRENOCHROME+MONOAMINOGUANIDINE+METHANESULFONATE | Search ADRENOCHROME+MONOAMINOGUANIDINE+METHANESULFONATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RYOMA, Y , MORIYA, Y , OKAMOTO, M , KANAYA, I , SAITO, M , SATO, M , (2004) BIOLOGICAL EFFECT OF OK-432 (PICIBANIL) AND POSSIBLE APPLICATION TO DENDRITIC CELL THERAPY.ANTICANCER RESEARCH. VOL. 24. ISSUE 5C. P. 3295-3301 | 42 | 66% | 22 |
2 | ABEL, U , VOGLER, S , (1992) TREATMENT OF MALIGNANT-TUMORS WITH THE STREPTOCOCCAL PREPARATION OK-432.TUMORDIAGNOSTIK & THERAPIE. VOL. 13. ISSUE 2. P. 43-48 | 36 | 86% | 0 |
3 | HOSOYA, Y , KOBAYASHI, E , TAKIZAWA, T , FUJIMURA, A , YASUDA, Y , NAGAI, H , KANAZAWA, K , (2005) EFFECT OF INTRAPERITONEAL NEUTROPHILS INDUCED BY OK432 ON MALIGNANT ASCITES.SURGERY TODAY. VOL. 35. ISSUE 1. P. 60-66 | 26 | 65% | 2 |
4 | TANO, T , OKAMOTO, M , KAN, S , NAKASHIRO, K , SHIMODAIRA, S , YAMASHITA, N , KAWAKAMI, Y , HAMAKAWA, H , (2012) GROWTH INHIBITION AND APOPTOSIS BY AN ACTIVE COMPONENT OF OK-432, A STREPTOCOCCAL AGENT, VIA TOLL-LIKE RECEPTOR 4 IN HUMAN HEAD AND NECK CANCER CELL LINES.ORAL ONCOLOGY. VOL. 48. ISSUE 8. P. 678 -685 | 21 | 58% | 6 |
5 | OSHIKAWA, T , OKAMOTO, M , TANO, T , SASAI, A , KAN, S , MORIYA, Y , RYOMA, Y , SAITO, M , AKIRA, S , SATO, M , (2006) ANTITUMOR EFFECT OF OK-432-DERIVED DNA - ONE OF THE ACTIVE CONSTITUENTS OF OK-432, A STREPTOCOCCAL IMMUNOTHEROPEUTIC AGENT.JOURNAL OF IMMUNOTHERAPY. VOL. 29. ISSUE 2. P. 143-150 | 19 | 58% | 13 |
6 | OHE, G , SASAI, A , UCHIDA, D , TAMATANI, T , NAGAI, H , MIYAMOTO, Y , (2013) EFFECT OF SOLUBLE FACTORS DERIVED FROM ORAL CANCER CELLS ON THE PRODUCTION OF INTERFERON-GAMMA FROM PERIPHERAL BLOOD MONONUCLEAR CELLS FOLLOWING STIMULATION WITH OK-432.ONCOLOGY REPORTS. VOL. 30. ISSUE 2. P. 945-951 | 18 | 51% | 0 |
7 | HOMMA, S , SAGAWA, Y , KOMITA, H , KOIDO, S , NAGASAKI, E , RYOMA, Y , OKAMOTO, M , (2007) MECHANISM OF ANTITUMOR EFFECT ON MOUSE HEPATOCELLULAR CARCINOMA BY INTRATUMORAL INJECTION OF OK-432, A STREPTOCOCCAL PREPARATION.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 56. ISSUE 8. P. 1265-1274 | 14 | 74% | 8 |
8 | OKAMOTO, M , OSHIKAWA, T , TANO, T , AHMED, SU , KAN, S , SASAI, A , AKASHI, S , MIYAKE, K , MORIYA, Y , RYOMA, Y , ET AL (2006) MECHANISM OF ANTICANCER HOST RESPONSE INDUCED BY OK-432, A STREPTOCOCCAL PREPARATION, MEDIATED BY PHAGOCYTOSIS AND TOLL-LIKE RECEPTOR 4 SIGNALING.JOURNAL OF IMMUNOTHERAPY. VOL. 29. ISSUE 1. P. 78-86 | 20 | 50% | 39 |
9 | KAGEYAMA, Y , SAKAI, Y , ARAI, G , HYOCHI, N , SUZUKI, M , MASUDA, H , KAWAKAMI, S , HAYASHI, T , OKUNO, T , KOBAYASHI, T , ET AL (2002) INTRACAVITARY ADMINISTRATION OF OK-432 WITH SUBCUTANEOUS PRIMING FOR MALIGNANT ASCITES IN A CASE OF ADVANCED RENAL CELL CARCINOMA.INTERNATIONAL JOURNAL OF UROLOGY. VOL. 9. ISSUE 1. P. 57-59 | 12 | 100% | 1 |
10 | YAMAGIWA, S , ICHIDA, T , SATO, K , SUGAHARA, S , YONEKURA, K , UCHIDA, M , UEHARA, K , KATOH, M , SATOH, H , ABO, T , ET AL (2000) LIPOSOME-ENCAPSULATED OK-432 SPECIFICALLY AND SUSTAINEDLY INDUCES HEPATIC NATURAL KILLER CELLS AND INTERMEDIATE T CELL RECEPTOR CELLS.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. VOL. 15. ISSUE 5. P. 542-549 | 18 | 64% | 1 |
Classes with closest relation at Level 1 |